BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRS
3026
DELISTED
Amyris Inc.
AMRS
| $15.2M | ﹤0.01% |
4,916,980
+1,109,265
| +29% | +$4.11M |
|
3027
Hurco Companies Inc
HURC
$144M
| $15.2M | ﹤0.01% |
395,547
-3,400
| -0.9% | -$120K |
|
|
DS
3028
DELISTED
Drive Shack Inc.
DS
| $15.1M | ﹤0.01% |
4,137,166
+192,069
| +5% | +$764K |
|
|
PMBC
3029
DELISTED
Pacific Mercantile Bancorp
PMBC
| $15.1M | ﹤0.01% |
1,863,196
+710,402
| +62% | +$5.2M |
|
3030
Graham Corp
GHM
$1.27B
| $15.1M | ﹤0.01% |
690,539
+7,693
| +1% | +$166K |
|
3031
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.5B
| $15.1M | ﹤0.01% |
432,593
+215,024
| +99% | +$7.18M |
|
|
FCBP
3032
DELISTED
First Choice Bancorp Common Stock
FCBP
| $15.1M | ﹤0.01% |
559,610
+8,486
| +2% | +$195K |
|
3033
Astrana Health
ASTH
$1.87B
| $15.1M | ﹤0.01% |
818,009
-993,142
| -55% | -$16.5M |
|
3034
Syndax Pharmaceuticals
SNDX
$1.84B
| $15.1M | ﹤0.01% |
1,714,481
+1,177
| +0.1% | +$8.64K |
|
3035
Minerva Neurosciences
NERV
$202M
| $15M | ﹤0.01% |
263,893
-36,817
| -12% | -$1.62M |
|
3036
First Internet Bancorp
INBK
$260M
| $15M | ﹤0.01% |
632,969
+14,556
| +2% | +$331K |
|
3037
BGSF Inc
BGSF
$59.3M
| $15M | ﹤0.01% |
684,743
+29,132
| +4% | +$593K |
|
|
CBIO
3038
Crescent Biopharma
CBIO
$646M
| $15M | ﹤0.01% |
28,285
-1,014
| -3% | -$549K |
|
3039
Castle Biosciences
CSTL
$1,000M
| $15M | ﹤0.01% |
435,174
+228,228
| +110% | +$5.58M |
|
|
VWTR
3040
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $14.9M | ﹤0.01% |
1,343,098
-4,309
| -0.3% | -$45.9K |
|
3041
Timberland Bancorp
TSBK
$350M
| $14.9M | ﹤0.01% |
502,028
+4,620
| +0.9% | +$129K |
|
3042
McEwen Inc
MUX
$1.17B
| $14.9M | ﹤0.01% |
1,173,939
+57,511
| +5% | +$813K |
|
3043
CALL
Micron Technology
MU
$987B
| $14.8M | ﹤0.01% |
+276,000
| New | +$13.2M |
|
|
SRGA
3044
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $14.8M | ﹤0.01% |
180,545
-1,935
| -1% | -$136K |
|
|
LTM
3045
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $14.8M | ﹤0.01% |
1,459,043
-495,570
| -25% | -$5.54M |
|
|
TBNK
3046
DELISTED
Territorial Bancorp Inc.
TBNK
| $14.8M | ﹤0.01% |
477,594
-472
| -0.1% | -$14.3K |
|
|
LBC
3047
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $14.7M | ﹤0.01% |
1,276,127
+17,825
| +1% | +$203K |
|
3048
Spyre Therapeutics
SYRE
$9.3B
| $14.7M | ﹤0.01% |
76,889
+788
| +1% | +$155K |
|
3049
Wave Life Sciences
WVE
$1.2B
| $14.7M | ﹤0.01% |
1,830,620
-5,176
| -0.3% | -$127K |
|
|
FPI
3050
Farmland Partners
FPI
$420M
| $14.6M | ﹤0.01% |
2,156,319
+18,959
| +0.9% | +$125K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.